TWD
RLAY icon

True Wealth Design’s Relay Therapeutics RLAY Stock Holding History

True Wealth Design’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5K Sell
267
-11
-4% -$160 ﹤0.01% 1328
2026
Q1 		$2.77K Hold
278
– – ﹤0.01% 1413
2025
Q4 		$2.35K Hold
278
– – ﹤0.01% 1393
2025
Q3 		$1.45K Buy
278
+163
+142% +$622 ﹤0.01% 1609
2025
Q2 		$398 Buy
115
+36
+46% +$107 ﹤0.01% 1833
2025
Q1 		$207 Buy
79
+11
+16% +$43 ﹤0.01% 1937
2024
Q4 		$281 Buy
+68
New +$370 ﹤0.01% 1175

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

True Wealth Design's RLAY Position: Q2 2026 in Review

True Wealth Design reduced its Relay Therapeutics (RLAY) stake by 4% in Q2 2026, selling an estimated $160 and leaving 267 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #1328.

True Wealth Design first reported a position in RLAY in Q4 2024 and has held it in 7 quarters since. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • True Wealth Design held 267 shares of Relay Therapeutics worth $5K as of Q2 2026.
  • True Wealth Design sold 11 Relay Therapeutics shares in Q2 2026, an estimated $160.
  • Relay Therapeutics made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #1328 holding.
  • True Wealth Design first reported a position in Relay Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.